Skip to content
★ Sign in to follow
AJ

August J. Moretti

4D Molecular Therapeutics, Inc.Depomed IncAlexza Pharmaceuticals Inc.
Total declarations
81
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (59 ops.)
€900k

Latest filing published 16 May 2023 for 4D Molecular Therapeutics, Inc., €26k.

Insider track record

Disclosed buys
0
Disclosed sells
59
Signal history

August J. Moretti: trading record in brief

August J. Moretti discloses dealings in 3 companies, chiefly Alexza Pharmaceuticals Inc., Depomed Inc and 4D Molecular Therapeutics, Inc. Between 7 December 2006 and 15 May 2023, the trades on record add up to 81 filings.

Every open-market trade on record is a sale: 59 sales worth €900k. Besides market trades, the filings include 8 share grants and 13 option exercises.

On 16 May 2023 came the latest disclosure, an option exercise for €26k in 4D Molecular Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to August J. Moretti

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations81 total
  • ◇
    Chief Financial OfficerExecutives4D Molecular Therapeutics, Inc.
    28,230 USD24SEC
    3,000 shares@ US$9.4149.4% of flowCommon StockSEC:0001610717-23-000044:0
  • ◇
    Chief Financial OfficerExecutives4D Molecular Therapeutics, Inc.
    28,230 USD24SEC
    3,000 shares@ US$9.4150.6% of flowCommon StockSEC:0001567619-22-021958:0
  • ◇
    Chief Financial OfficerExecutives4D Molecular Therapeutics, Inc.
    9,410 USD20SEC
    1,000 shares@ US$9.4113.1% of flowCommon StockSEC:0001567619-21-008045:0
  • ◆
    Chief Financial Officer & SVPExecutivesDepomed Inc
    45,965 USD20SEC
    6,975 shares@ US$6.595.5% of flowCommon stockSEC:0001179110-18-005346:0
  • ◆
    Chief Financial Officer & SVPExecutivesDepomed Inc
    73,489 USD20SEC
    10,336 shares@ US$7.119.1% of flowCommon stockSEC:0001179110-17-014989:0
  • ◆
    Chief Financial Officer & SVPExecutivesDepomed Inc
    11,797 USD19SEC
    940 shares@ US$12.551.6% of flowCommon stockSEC:0001179110-17-005722:0
  • ◆
    Chief Financial Officer & SVPExecutivesDepomed Inc
    201,323 USD22SEC
    10,853 shares@ US$18.5528.0% of flowCommon stockSEC:0001179110-16-032498:0
  • ◇
    Chief Financial Officer & SVPExecutivesDepomed Inc
    63,450 USD20SEC
    5,000 shares@ US$12.698.6% of flowCommon StockSEC:0001179110-16-031609:0
  • ▼
    Chief Financial Officer & SVPExecutivesDepomed Inc
    104,200 USD20SEC
    5,000 shares@ US$20.8414.2% of flowCommon StockSEC:0001179110-16-031609:1
  • ▼
    Chief Financial Officer & SVPExecutivesDepomed Inc
    36,444 USD31SEC
    1,703 shares@ US$21.404.8% of flowCommon stockSEC:0001179110-16-028587:0
  • ◇
    Chief Financial Officer & SVPExecutivesDepomed Inc
    41,839 USD20SEC
    3,297 shares@ US$12.695.5% of flowCommon StockSEC:0001179110-16-028587:1
  • ▼
    Chief Financial Officer & SVPExecutivesDepomed Inc
    70,556 USD32SEC
    3,297 shares@ US$21.409.3% of flowCommon StockSEC:0001179110-16-028587:2
  • ▼
    Chief Financial Officer & SVPExecutivesDepomed Inc
    90,000 USD20SEC
    5,000 shares@ US$18.0011.6% of flowCommon stockSEC:0001179110-16-024187:0
  • ◆
    Chief Financial Officer & SVPExecutivesDepomed Inc
    13,517 USD19SEC
    940 shares@ US$14.381.7% of flowCommon stockSEC:0001179110-16-022836:0
  • ◇
    Chief Financial Officer & SVPExecutivesDepomed Inc
    26,750 USD0SEC
    5,000 shares@ US$5.35Common StockSEC:0001179110-15-016396:0
  • ◆
    Chief Financial Officer & SVPExecutivesDepomed Inc
    139,251 USD0SEC
    7,329 shares@ US$19.00Common stockSEC:0001179110-15-015767:0
  • ▼
    Chief Financial Officer & SVPExecutivesDepomed Inc
    238,441 USD0SEC
    13,159 shares@ US$18.12Common StockSEC:0001179110-15-015767:1
  • ▼
    Chief Financial Officer & SVPExecutivesDepomed Inc
    33,156 USD0SEC
    1,841 shares@ US$18.01Common StockSEC:0001179110-15-015767:2
  • ▼
    Chief Financial OfficerExecutivesDepomed Inc
    84,623 USD0SEC
    5,339 shares@ US$15.85Common StockSEC:0001179110-14-017515:0
  • ▼
    Chief Financial OfficerExecutivesDepomed Inc
    23,696 USD0SEC
    2,821 shares@ US$8.40Common StockSEC:0001179110-13-017421:0
  • ◇
    Chief Financial OfficerExecutivesDepomed Inc
    13,375 USD0SEC
    2,500 shares@ US$5.35Common StockSEC:0001179110-13-008678:0
  • ◆
    SVP, CFO, GC & SecExecutivesAlexza Pharmaceuticals Inc.
    0SEC
    45,582 shares0Common StockSEC:0001209191-11-004444:0
  • ◇
    SVP, CFO & SecExecutivesAlexza Pharmaceuticals Inc.
    13,800 USD0SEC
    10,000 shares@ US$1.38Common StockSEC:0001209191-10-026102:0
  • ▼
    SVP, CFO & SecExecutivesAlexza Pharmaceuticals Inc.
    35,000 USD0SEC
    10,000 shares@ US$3.50Common StockSEC:0001209191-10-026102:1
  • ▼
    SVP, CFO & SecExecutivesAlexza Pharmaceuticals Inc.
    10,681 USD0SEC
    4,432 shares@ US$2.41Common StockSEC:0001209191-09-058154:0

25 of 81 declarations